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Introduction {#sec001}
============

Myostatin (MSTN) is a secreted growth factor and a member of the TGF-β superfamily that functions as a critical autocrine/paracrine inhibitor and negatively regulates skeletal muscle growth and development through the regulation of anabolic and catabolic pathways in skeletal muscles \[[@pone.0187966.ref001]\]. Myostatin is expressed almost exclusively in skeletal muscle \[[@pone.0187966.ref002]\]. Mutations in the coding region of *MSTN* result in a double-muscling phenotype in many species, including cattle \[[@pone.0187966.ref003], [@pone.0187966.ref004]\], mice \[[@pone.0187966.ref005]--[@pone.0187966.ref007]\] and humans \[[@pone.0187966.ref008]\]. Myostatin both regulates lean tissue mass and affects body fat content in mice \[[@pone.0187966.ref009]\]. In *MSTN* knockout mice (*MSTN*^*-/-*^), the absence of *MSTN* results in increased skeletal muscle mass, reduced fat tissue, increased insulin sensitivity, enhanced fatty acid oxidation, and an elevated resistance to obesity \[[@pone.0187966.ref006], [@pone.0187966.ref010]\], whereas overexpression of myostatin induces muscle atrophy \[[@pone.0187966.ref011]\]. Consequently, a number of strategies to block the effects of myostatin have been developed and tested in various models of neuromuscular disorders, muscle-wasting conditions or metabolic disturbances \[[@pone.0187966.ref012]--[@pone.0187966.ref014]\]. Mice with Lewis Lung carcinoma treated with ActRIIB-Fc, a soluble myostatin receptor that binds myostatin, showed increased body weight and muscle weight as well as significantly increased grip strength \[[@pone.0187966.ref015]\]. In *mdx* mice, a model for Duchenne muscular dystrophy, an antibody-mediated myostatin blockade was found to ameliorate the pathophysiology and muscle weakness associated with this condition \[[@pone.0187966.ref016]\]. However, these strategies have less efficiency in blocking the effects of myostatin.

Natural myostatin gene mutations occur in cattle breeds such as the Belgian Blue, which exhibits obviously increased muscle mass \[[@pone.0187966.ref017]\]. Muscular hypertrophy, or the double-muscle phenotype, is a heritable condition in cattle \[[@pone.0187966.ref003]\]. The Shaanbei Cashmere goat is a local breed in China that produces both fiber and meat products. The meat is renowned for its lower fat content compared to that of beef and lamb \[[@pone.0187966.ref018]\], and thus, it is recommended as a healthy food for consumers. To increase meat production in goats, efforts aimed at the development of strategies to significantly increase muscle growth by manipulating *MSTN* gene expression have been intensively undertaken \[[@pone.0187966.ref019]\].

High-throughput mRNA sequencing (RNA-seq) offers the ability to discover new genes and transcripts and to measure both transcript abundance and expression in a single experiment \[[@pone.0187966.ref020], [@pone.0187966.ref021]\]. Based on RNA-seq technology, we measured the integrated global gene expression and signaling pathway activities in goats after *MSTN* gene knockout. Microarray technology enables a broad overview of the impact of treatments on the expression of all known genes, and this technology has been already been used to examine the effects of constitutive *MSTN* deficiency in mice and cattle \[[@pone.0187966.ref022]--[@pone.0187966.ref025]\]. However, high-throughput mRNA sequencing (RNA-Seq) offers the ability to discover new genes and transcripts and to measure transcript expression levels in a single assay \[[@pone.0187966.ref026]--[@pone.0187966.ref028]\]. Many studies have shown that RNA-Seq is more accurate over a greater dynamic range of gene expression than expression microarrays \[[@pone.0187966.ref029], [@pone.0187966.ref030]\]. Recently, genome-wide gene expression profiling has gained ground due to the development and application of large-scale sequencing techniques to obtain gene sequences and develop molecular markers, especially in less researched species \[[@pone.0187966.ref031]--[@pone.0187966.ref034]\].

Wang et al. recently reported the successful application of the CRISPR/Cas9 system to manipulate the goat genome \[[@pone.0187966.ref035]\]. They also demonstrated the utility of this approach by disrupting *MSTN*, which resulted in enhanced body weight and larger muscle fibers in goats with Cas9-mediated genetic modifications. They further characterized the effects of these genome modifications by hematoxylin and eosin (H&E) staining, quantitative PCR, Western blotting, and immunofluorescence staining (Animal Genetics, under review). However, a transcriptomic analysis of the changes in either gene expression or lipid metabolism in *MSTN* knockout goats has not been reported.

*MSTN* was initially characterized as a potent inhibitor of skeletal muscle growth and development \[[@pone.0187966.ref036]\]. However, its role in the regulation of glucose and lipid metabolism has gained significant attention \[[@pone.0187966.ref009], [@pone.0187966.ref037]--[@pone.0187966.ref040]\]. The goals of this study were to identify important candidate genes related to muscle, glucose and lipid metabolism and to further determine the transcriptomic changes using RNA-Seq. These results will provide valuable information about key genes in this species and improve our understanding of the molecular mechanisms regulating muscle, glucose and lipid metabolism in goats.

Materials and methods {#sec002}
=====================

Ethics statement {#sec003}
----------------

All animal experiments and procedures were carried out in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals by the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of Northwest A&F University (Approval ID: 2014ZX08008-002).

Animal samples {#sec004}
--------------

The animals used in the present study were previously generated by Wang et al. \[[@pone.0187966.ref035]\]. The genotypes of three *MSTN*- and *FGF5*-disrupted goats and three *FGF5*-disrupted goats are summarized in [S1 Table](#pone.0187966.s002){ref-type="supplementary-material"}. All animals were raised in the same way under natural light with free access to water and food at the Shaanbei Cashmere Goat Farm at Yulin University. Longissimus dorsi muscles were obtained from nine one-year-old Shaanbei Cashmere goats: three wild-type (WT) goats (each was determined to possess an unedited genome), three goats with only the *fibroblast growth factor 5* (*FGF5*) gene knocked out (FGF5^+/-^ group) and three goats with disruptions in both the *FGF5* and *MSTN* genes (FM^+/-^ group). The transgenic goats were generated using the CRISPR/Cas9 system. Fresh longissimus dorsi muscle samples were harvested immediately from goats after surgery under local anesthesia using 3 mL of procaine (1%) injected into the skin/muscle tissues. All efforts were made to minimize animal suffering and to reduce the number of animals used. Obtained fresh longissimus dorsi muscle samples were washed with sterile normal saline three times, frozen in RNAlater (Takara, Dalian, China) using liquid nitrogen, and sent to Novogene Bioinformatics Technology Co. Ltd. (Beijing, China).

RNA extraction and preparation {#sec005}
------------------------------

Genome-wide transcriptome libraries were constructed from the three sets of muscle samples from the WT, FGF5^+/-^ and FM^+/-^ goats. Longissimus dorsi muscle tissue blocks containing approximately 80--100 mg of tissue were dissolved in TRIzol reagent (Invitrogen, USA) for total RNA extraction. RNA degradation and contamination were monitored by electrophoresis in 1% agarose gels. The quality and quantity of RNA were checked using a NanoPhotometer® spectrophotometer (IMPLEN, CA, USA) and a Qubit® RNA Assay Kit in a Qubit® 2.0 Fluorometer (Life Technologies, CA, USA). RNA integrity was assessed using an RNA Nano 6000 Assay Kit and a Bioanalyzer 2100 system (Agilent Technologies, CA, USA).

mRNA-Seq library preparation and sequencing {#sec006}
-------------------------------------------

Illumina® (NEB, USA) mRNA-Seq libraries were prepared with 3 μg of total RNA using the NEBNext® Ultra™ RNA Library Prep Kit according to the manufacturer's instructions, and index codes were added to attribute the sequences to each sample. Briefly, RNA was purified from total RNA using Poly-T oligo-attached magnetic beads. Fragmentation was carried out using divalent cations under elevated temperature conditions in NEBNext First Strand Synthesis Reaction Buffer (5x). First-strand cDNA was synthesized using random hexamer primers and M-MLV Reverse Transcriptase (RNase H minus). Second-strand cDNA synthesis was subsequently performed using DNA Polymerase I and RNase H. Remaining overhangs were converted into blunt ends via exonuclease/polymerase activities. After adenylation of the 3' ends of cDNA fragments, a NEBNext Adaptor with a hairpin loop structure was ligated to prepare the cDNA for hybridization. To preferentially select cDNA fragments of 150\~200 bp in length, the library fragments were purified with the AMPure XP system (Beckman Coulter, Beverly, USA). Then, 3 μL of USER Enzyme (NEB, USA) was used with size-selected, adaptor-ligated cDNA at 37°C for 15 min followed by 5 min at 95°C before PCR. Then, PCR was performed with Phusion High-Fidelity DNA polymerase, Universal PCR primers and Index (X) Primer. Finally, the PCR products were purified (AMPure XP system), and the library quality was assessed using the Agilent Bioanalyzer 2100 system.

Clustering of the index-coded samples was performed on a cBot Cluster Generation System using the TruSeq PE Cluster Kit v3-cBot-HS (Illumina) according to the manufacturer's instructions. After cluster generation, the library preparations were sequenced on an Illumina HiSeq 2000 platform, and 100-bp paired-end reads were generated.

Quality control and read mapping to the reference genome {#sec007}
--------------------------------------------------------

Raw data (raw reads) in the FASTQ format were first processed using in-house Perl scripts and the Q20, Q30 and GC contents of the clean data were calculated.

For mapping, an index of the reference genome was built using Bowtie v2.0.6, and paired-end clean reads were aligned to the reference genome using TopHat v2.0.9.

Gene expression {#sec008}
---------------

The counts of the read numbers mapped to each gene were processed by HTSeq v0.6.1, and the FPKM (expected number of fragments per kilobase sequence per million base pairs sequenced) of each gene was calculated based on the length of the gene and the reads count mapped to that gene \[[@pone.0187966.ref041]\]. The FPKM considers both the effect of sequencing depth and gene length for the read count and is currently the most commonly used method for estimating gene expression levels \[[@pone.0187966.ref042]\].

DEGs were identified using the R package "DESeq" (1.10.1) with raw gene counts as the input, and quantile normalization was applied for variable library sizes. DESeq provides statistical routines for determining differential expression in digital gene expression data using a model based on the negative binomial distribution. The resulting *P*-values were adjusted using the Benjamini and Hochberg's approach for controlling the false discovery rate \[[@pone.0187966.ref043]\]. Differentially expressed genes (DEGs) were determined by DEGseq with a cutoff threshold of *P*-value \< 0.05 \[[@pone.0187966.ref044]\].

Differential gene functional annotation {#sec009}
---------------------------------------

Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes databases (KEGG, <http://www.genome.jp/kegg>) enrichment was analyzed using differential genes as the foreground and all genes as the background for the identified differential transcripts. GO enrichment analysis of the DEGs was performed using the GOseq R package \[[@pone.0187966.ref045]\], in which gene length bias was corrected. GO terms with corrected *P-*values \< 0.05 were considered significantly enriched by DEGs.

The KEGG is a database resource for understanding high-level functions and utilities of the biological system \[[@pone.0187966.ref046]\]. KEGG Orthology Based Annotation System (KOBAS, 2.0) software was used to test the statistical enrichment of differentially expression genes in the KEGG pathways.

qRT-PCR analysis for the validation of RNA-Seq data {#sec010}
---------------------------------------------------

Real-time quantitative reverse transcription PCR (qRT-PCR) was used to validate the RNA-Seq data. The total RNA isolated for RNA sequencing was used to perform qRT-PCR. Reverse transcription was performed with 1 μg of total RNA using the PrimeScript RT Reagent Kit (Invitrogen, USA). Real-time quantitative PCR analyses were then performed with a Bio-Rad IQ5 Optical System; individual reactions were prepared with 5 ng of cDNA and SYBR Green PCR master mix (Takara, Dalian, China) in a final volume of 20 μL. All reactions were performed in triplicate. Cycle threshold (Ct) values were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and comparative quantification of mRNA was performed using the 2^-ΔΔCt^ method. The primer sequences used in the qPCR assay are provided in [S2 Table](#pone.0187966.s003){ref-type="supplementary-material"} \[[@pone.0187966.ref047]--[@pone.0187966.ref049]\].

Statistical analysis {#sec011}
--------------------

All data are presented as the means ± standard deviation (SD), and comparisons were performed by analysis of variance (ANOVA) (SAS). A probability of less than 0.05 was considered to be statistically significant.

Results {#sec012}
=======

Summary of the raw sequence reads and DEGs {#sec013}
------------------------------------------

To understand the gene expression profiles and differences between the three samples at transcript resolution, we performed RNA-Seq on three cDNA sequencing libraries constructed using muscle tissues from WT, FGF5^+/-^ and FM^+/-^ goats. We then mapped the filtered clean reads to the reference goat genome CHIR-1.0 ([Table 1](#pone.0187966.t001){ref-type="table"}). In total, we obtained 68.93, 62.04 and 66.26 million reads for the sequencing libraries constructed from the WT, FGF5^+/-^ and FM^+/-^ goat muscle tissues, respectively. We found that in each sample, \~73% of reads could be mapped to the reference genome, which is comparable to the reports for two non-model organisms, swine \[[@pone.0187966.ref050]\] and bovine \[[@pone.0187966.ref051]\], in which 61.4--75.0% of reads are mapped to the reference genome. Thus, our mapping percentage suggests good sequence quality.

10.1371/journal.pone.0187966.t001

###### Statistics of the Illumina RNA-Seq reads in the normal and transgenic goat muscle libraries that were mapped to the goat reference genome CHIR-1.0.

![](pone.0187966.t001){#pone.0187966.t001g}

  Summary statistics            Number     Percentage   Number     Percentage   Number     Percentage
  ----------------------------- ---------- ------------ ---------- ------------ ---------- ------------
  Total raw reads               70553433                63677463                67796573   
  Total mapped                  51626789   74.99%       45847205   73.90%       48958298   73.90%
  Total clean reads             68933544                62036347                66257588   
  Total clean base pairs (Gb)   10.34 Gb                9.30 Gb                 9.94 Gb    
  Read map to \'+\'             25346942   36.81%       22469249   36.22%       24050354   36.30%
  Read map to \'-\'             25053573   36.39%       22207247   35.80%       23732089   35.83%
  Multiply mapped               1226274    1.79%        1170709    1.89%        1175855    1.77%
  Uniquely mapped               50400515   73.00%       44676496   72.01%       47782443   72.13%
  Non-splice reads              25925041   37.59%       22021886   35.52%       24005700   36.24%
  Splice reads                  24475474   35.61%       22654610   36.49%       23776743   35.88%

Identification of DEGs {#sec014}
----------------------

The read count data obtained from the transcriptome were used to analyze differences in gene expression. We obtained 201 DEGs, including 115 up-regulated genes and 86 down-regulated genes, between the FGF5^+/-^ group and the WT group. Moreover, 121 DEGs, including 40 up-regulated genes and 81 down-regulated genes, were identified between the FM^+/-^ group and the WT group. A total of 198 DEGs, including 70 up-regulated genes and 128 down-regulated genes, were identified between the FM^+/-^ group and the FGF5^+/-^ group. We used a false discovery rate (FDR) ≤ 0.001 and an absolute value of the log2 ratio ≥ 1 as the threshold to judge the significance of differences in gene expression. Library size-normalized counts for the three samples were generated, and volcano plots for the DEGs are shown in [Fig 1A, 1B and 1C](#pone.0187966.g001){ref-type="fig"}. A Venn diagram showing the number of DEGs among the three pairwise comparisons is shown in [Fig 1D](#pone.0187966.g001){ref-type="fig"}. Hierarchical clustering showed the expression profiles of the top 40 DEGs ([Fig 2](#pone.0187966.g002){ref-type="fig"}). The full names of the top 20 DEGs in the WT, FM^+/-^ and FGF5^+/-^ goats and their functional characteristics are shown in [Table 2](#pone.0187966.t002){ref-type="table"} \[[@pone.0187966.ref052]--[@pone.0187966.ref070]\].

![Differentially expressed genes in the RNA-Seq data.\
Volcano plot of statistically significant differentially expressed genes at P ≤ 0.05 identified from the RNA-Seq libraries of normal and transgenic goat muscle (1A, 1B, 1C). A Venn diagram showing the DEGs identified from comparisons of FGF5^+/-^ vs WT goats, FM^+/-^ vs WT goats and FM^+/-^ vs FGF5^+/-^ goats (1D).](pone.0187966.g001){#pone.0187966.g001}

![A hierarchically clustered heatmap showing the expression patterns of the 40 most DEGs.\
The red blocks represent the overexpressed genes, and the blue blocks represent genes with the lowest expression levels. Colored bars indicate the expression levels.](pone.0187966.g002){#pone.0187966.g002}

10.1371/journal.pone.0187966.t002

###### Biological functions of the 20 most differentially expressed genes in the longissimus dorsi muscle identified by pairwise comparisons of FGF5^+/-^ vs WT, FM^+/-^ vs WT and FM^+/-^ vs FGF5^+/-^.
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  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene ID     Symbol         Summary
  ----------- -------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  100861382   KRT27          This gene encodes a member of the type I (acidic) keratin family, which belongs to the superfamily of intermediate filament (IF) proteins that is essential for the proper assembly of type I and type II keratin protein complexes and the formation of keratin intermediate filaments in the inner root sheath (IRS) \[[@pone.0187966.ref052]\].

  102168539   ROR2           The protein encoded by this gene is a receptor protein tyrosine kinase and type I transmembrane protein that belongs to the ROR subfamily of cell surface receptors. The protein may be involved in the early formation of the chondrocytes and may be required for cartilage and growth plate development \[[@pone.0187966.ref053]\].

  102169758   NUDT2          This gene encodes a member of the MutT family of nucleotide pyrophosphatases, a subset of the larger NUDIX hydrolase family. The gene may be a candidate tumor suppressor gene \[[@pone.0187966.ref054]\].

  102168410   GJC3           This gene encodes a gap junction protein. The encoded protein is a connexin that plays a role in the formation of gap junctions, which provide direct connections between adjacent cells \[[@pone.0187966.ref055]\].

  102168261   EPHA7          Activation of the protein encoded by this gene results in activating phosphorylation of components of the ERK signaling pathway, including MAP2K1, MAP2K2, MAPK1 and MAPK3 \[[@pone.0187966.ref056]\].

  102168984   TNMD           The gene tenomodulin (TNMD) is a tendon-specific marker known to be important for tendon maturation, with key implications for the residing tendon stem/progenitor cells and for the regulation of endothelial cell migration in chordae tendineae cordis in the heart and in experimental tumor models \[[@pone.0187966.ref057]\]. Myostatin has a potential role in the induction of tenogenic differentiation of C2C12 cells \[[@pone.0187966.ref058]\].

  102169639   MIB1           This gene encodes a protein that contains multiple ankyrin repeats and RING finger domains and functions as an E3 ubiquitin ligase. The encoded protein positively regulates Notch signaling by ubiquitinating Notch receptors, thereby facilitating Notch receptor endocytosis. This protein may also promote the ubiquitination and degradation of death-associated protein kinase 1 (DAPK1) \[[@pone.0187966.ref059]\].

  102169348   CDH19          This gene is one of three related type II cadherin genes situated in a cluster on chromosome 18.\
                             The encoded protein is a calcium-dependent cell-cell adhesion glycoprotein containing five extracellular cadherin repeats.\
                             CDH19 plays important roles in cell adhesion and in the formation of adherens junctions, which bind cells together within tissues \[[@pone.0187966.ref060]\].

  102169909   ARL15          The function of this gene has yet to be established.

  102168680   LOC102168680   The function of this gene has yet to be established.

  102169025   SLC24A3        Plasma membrane sodium/calcium exchangers play important roles in intracellular calcium homeostasis and electrical conduction. Potassium-dependent sodium/calcium exchangers such as SLC24A3 are believed to exchange 1 intracellular calcium ion and 1 potassium ion for 4 extracellular sodium ions \[[@pone.0187966.ref061]\]. 

  102169863   EGFL6          This gene encodes a member of the epidermal growth factor (EGF) repeat superfamily.\
                             Members of this superfamily are characterized by the presence of EGF-like repeats and are often involved in the regulation of the cell cycle, proliferation, and developmental processes \[[@pone.0187966.ref062]\].

  100860763   SCD            Stearoyl-CoA desaturase (Δ-9-desaturase) is an endoplasmic reticulum enzyme that catalyzes the rate-limiting step in the formation of monounsaturated fatty acids (MUFAs), specifically oleate and palmitoleate, from stearoyl-CoA and palmitoyl-CoA \[[@pone.0187966.ref063]\].

  102169918   HECW2          This gene encodes a member of a family of E3 ubiquitin ligases that plays an important role in the proliferation, migration and differentiation of neural crest cells via the regulation of glial cell line-derived neurotrophic factor (GDNF)/Ret signaling. This gene also plays an important role in angiogenesis by stabilizing endothelial cell-to-cell junctions via the regulation of angiomotin-like 1 stability \[[@pone.0187966.ref064]\].

  100861286   FASN           Fatty acid synthase is a multi-enzyme protein that catalyzes fatty acid synthesis.\
                             Its main function is to catalyze the synthesis of palmitate (C16:0), a long-chain saturated fatty acid, from acetyl-CoA and malonyl-CoA in the presence of NADPH \[[@pone.0187966.ref065]\].

  102168503   DOK6           DOK6 is a member of the DOK (see DOK1; MIM 602919) family of intracellular adaptors that plays a role in the RET (MIM 164761) signaling cascade \[[@pone.0187966.ref066]\].

  102168351   TIAM2          This gene encodes a guanine nucleotide exchange factor. A highly similar mouse protein specifically activates ras-related C3 botulinum substrate 1, converting this Rho-like guanosine triphosphatase (GTPase) from an inactive, guanosine diphosphate-bound state to an active, guanosine triphosphate-bound state. The encoded protein may also play a role in neural cell development \[[@pone.0187966.ref067]\].

  102170054   MERTK          This gene encodes a member of the MER/AXL/TYRO3 receptor kinase family. The encoded transmembrane protein contains two fibronectin type-III domains, two Ig-like C2-type (immunoglobulin-like) domains, and one tyrosine kinase domain. Mutations in this gene have been associated with disruption of the retinal pigment epithelium (RPE) phagocytosis pathway and the onset of autosomal recessive retinitis pigmentosa \[[@pone.0187966.ref068]\].

  100860988   TPMT           Thiopurine methyltransferase methylates thiopurine compounds. The methyl donor is S-adenosyl-L-methionine, which is converted to S-adenosyl-L-homocysteine. This enzyme uses S-adenosyl-L-methionine as an S-methyl donor to metabolize thiopurine drugs, producing S-adenosyl-L-homocysteine as a byproduct \[[@pone.0187966.ref069]\].

  102169914   KLHL23         The protein encoded by this gene is a member of the kelch family of proteins, which is characterized by a 44--56 amino acid repeat motif. The kelch motif appears in many different polypeptide contexts and contains multiple potential protein-protein contact sites. Members of this family have diverse activities and are present both throughout the cell and extracellularly \[[@pone.0187966.ref070]\].
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Functional enrichment of DEGs {#sec015}
-----------------------------

The identified DEGs were further analyzed using GO and KEGG enrichment to determine their potential functions and metabolic pathways.

GO analysis based on biological process (BP) enrichment was performed for sets of DEGs with significant cluster profiles. Only significant GO categories with *P-*values \< 0.05 were chosen for analysis. The results of the GO enrichment analysis of DEGs were classified into three categories: BP, cellular component (CC) and molecular function (MF). [Fig 3](#pone.0187966.g003){ref-type="fig"} shows the GO classifications of the DEGs from the comparisons between FGF5^+/-^ and WT goats, FM^+/-^ and WT goats, and FM^+/-^ and FGF5^+/-^ goats.

![Gene ontology analysis summary.\
Classification of the annotated amino-acid sequences. Amino-acid sequences were grouped into different functional subcategories: cellular component (CC), molecular function (MF) and biological process (BF). 3A: FGF5^+/-^ vs WT; 3B: FM^+/-^ vs WT; and 3C: FM^+/-^ vs FGF5^+/-^.](pone.0187966.g003){#pone.0187966.g003}

The top 20 up- and down-regulated gene-enriched GO terms are shown in Tables [3](#pone.0187966.t003){ref-type="table"} and [4](#pone.0187966.t004){ref-type="table"}. By comparing the gene list of FGF5^+/-^ goats with that of WT goats, two major GO terms relevant to muscle contraction \[(actin cytoskeleton and myosin heavy chain (MHC) protein complex)\] were identified ([Fig 3A](#pone.0187966.g003){ref-type="fig"}). The machinery that powers cell migration is built from the actin cytoskeleton, which is larger than any organelle, and the assembly or disassembly of the actin cytoskeleton can easily change cell morphology \[[@pone.0187966.ref071]\]. The distribution of enriched GO terms between gene lists of FM^+/-^ and WT goats is shown in [Fig 3B](#pone.0187966.g003){ref-type="fig"}. Moreover, the myosin complex and actin cytoskeleton were significantly enriched in the CC. Myosin comprises a superfamily of ATP-dependent motor proteins and is best known for its roles in muscle contraction and its involvement in a wide range of other motility processes in eukaryotes \[[@pone.0187966.ref072]\]. In terms of BPs, several processes in the fatty acid metabolic system, including peptide metabolism, protein processing and cellular amide metabolism, were found to be enriched in the genes down-regulated in FM^+/-^ goats compared with their expression in WT goats. There were several major enriched GO terms in the comparison of gene lists from FM^+/-^ and FGF5^+/-^ goats ([Fig 3C](#pone.0187966.g003){ref-type="fig"}).

10.1371/journal.pone.0187966.t003

###### The top 20 GO terms of significantly up-regulated genes.
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  ---------------------------------------------------------------------------------------------------------------------------------
  Treatments             GO ID         Category              GO description                                         *P*-Value
  ---------------------- ------------- --------------------- ------------------------------------------------------ ---------------
  FGF5^+/-^ vs WT        GO:0015629    cellular component    actin cytoskeleton                                     4.29E-06

                         GO:0042611    cellular component    MHC protein complex                                    4.45E-05

                         GO:0019882    biological process    antigen processing and presentation                    7.64E-05

                         GO:0016459    cellular component    myosin complex                                         1.45x10^-4^

                         GO:0042613    cellular component    MHC class II protein complex                           2.97 x10^-4^

                         GO:0003774    molecular function    motor activity                                         3.38 x10^-4^

                         GO:0005861    cellular component    troponin complex                                       6.65 x10^-4^

                         GO:0005865    cellular component    striated muscle thin filament                          6.65 x10^-4^

                         GO:0030016    cellular component    myofibril                                              6.65 x10^-4^

                         GO:0030017    cellular component    sarcomere                                              6.65 x10^-4^

                         GO:0036379\   cellular component\   myofilament\                                           6.65 x10^-4^\
                         GO:0043292\   cellular component\   contractile fiber\                                     6.65 x10^-4^\
                         GO:0044449    cellular component    contractile fiber part                                 6.65 x10^-4^

                         GO:0005886    cellular component    plasma membrane                                        1.31x10^-3^

                         GO:0044281    biological process    small molecule metabolic process                       1.44x10^-3^

                         GO:0032182    molecular function    mall conjugating protein bindings                      1.72 x10^-3^

                         GO:0043130    molecular function    ubiquitin binding                                      1.72 x10^-3^

                         GO:0017119    cellular component    Golgi transport complex                                1.96 x10^-3^

                         GO:0006206    biological process    pyrimidine nucleobase metabolic process                2.78 x10^-3^

                         GO:0019856    biological process    pyrimidine nucleobase biosynthetic process             2.78 x10^-3^

  FM^+/-^ vs WT          GO:0016459    cellular component    myosin complex                                         2.68E-06

                         GO:0015629    cellular component    actin cytoskeleton                                     1.46E-05

                         GO:0003774    molecular function    motor activity                                         6.82E-05

                         GO:0030131    cellular component    clathrin adaptor complex                               1.14 x10^-3^

                         GO:0030119    cellular component    AP-type membrane coat adaptor complex                  1.39 x10^-3^

                         GO:0030118    cellular component    clathrin coat                                          1.85 x10^-3^

                         GO:0016192    biological process    vesicle-mediated transport                             3.12 x10^-3^

                         GO:0044430    cellular component    cytoskeletal part                                      3.62 x10^-3^

                         GO:0009755    biological process    hormone-mediated signaling pathway                     4.8 x10^-3^

                         GO:0032870    biological process    cellular response to hormone stimulus                  4.8 x10^-3^

                         GO:0071495    biological process    cellular response to endogenous stimulus               4.97 x10^-3^

                         GO:0005575    cellular component    cellular component                                     5.13 x10^-3^

                         GO:0005388    molecular function    calcium-transporting ATPase activity                   5.18 x10^-3^

                         GO:0071310    biological process    cellular response to organic substance                 5.29 x10^-3^

                         GO:0009725    biological process    response to hormone stimulus                           5.29 x10^-3^

                         GO:0009719    biological process    response to endogenous stimulus                        5.45 x10^-3^

                         GO:0005856    cellular component    cytoskeleton                                           5.95 x10^-3^

                         GO:0070887    biological process    cellular response to chemical stimulus                 6.49 x10^-3^

                         GO:0010033    biological process    response to organic substance                          6.67 x10^-3^

                         GO:0009399    biological process    nitrogen fixation                                      6.89 x10^-3^

  FM^+/-^ vs FGF5^+/-^   GO:0004853    molecular function    uroporphyrinogen decarboxylase activity                4.70E-05

                         GO:0034220    biological process    ion transmembrane transport                            1.72 x10^-3^

                         GO:0031090    cellular component    organelle membrane                                     2.2 x10^-3^

                         GO:0065008    biological process    regulation of biological quality                       2.72 x10^-3^

                         GO:0035435    biological process    phosphate ion transmembrane transport                  3.82 x10^-3^

                         GO:0019725    biological process    cellular homeostasis                                   4.22 x10^-3^

                         GO:0015672    biological process    monovalent inorganic cation transport                  5.14 x10^-3^

                         GO:0006779    biological process    porphyrin-containing compound biosynthetic process     5.56 x10^-3^

                         GO:0042592    biological process    homeostatic process                                    7.41 x10^-3^

                         GO:0006778    biological process    porphyrin-containing compound metabolic process        7.66 x10^-3^

                         GO:0006811    biological process    ion transport                                          8.43 x10^-3^

                         GO:0051701    biological process    interaction with host                                  9.33 x10^-3^

                         GO:0004427    molecular function    inorganic diphosphatase activity                       9.39 x10^-3^

                         GO:0033014    biological process    tetrapyrrole biosynthetic process                      0.01

                         GO:0005388    molecular function    calcium-transporting ATPase activity                   0.01

                         GO:0006812    biological process    cation transport                                       0.01

                         GO:0015114    molecular function    phosphate ion transmembrane transporter activity       0.01

                         GO:0033013    biological process    tetrapyrrole metabolic process                         0.01

                         GO:0045454    biological process    cell redox homeostasis                                 0.01

                         GO:0019048    biological process    modulation by virus of host morphology or physiology   0.01
  ---------------------------------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0187966.t004

###### The top 20 GO terms of significantly down-regulated genes.

![](pone.0187966.t004){#pone.0187966.t004g}

  Treatments             GO ID        Category             GO description                                                 *P*-Value
  ---------------------- ------------ -------------------- -------------------------------------------------------------- --------------
  FGF5^+/-^ vs WT        GO:0009055   molecular function   electron carrier activity                                      1.95 x10^-3^
                         GO:0019911   molecular function   structural constituent of myelin sheath                        3.11 x10^-3^
                         GO:0015109   molecular function   chromate transmembrane transporter activity                    3.89 x10^-3^
                         GO:0015703   biological process   chromate transport                                             3.89 x10^-3^
                         GO:0005198   molecular function   structural molecule activity                                   7.78 x10^-3^
                         GO:0045502   molecular function   dynein binding                                                 9.59 x10^-3^
                         GO:0008813   molecular function   chorismate lyase activity                                      0.01
                         GO:0005515   molecular function   protein binding                                                0.01
                         GO:0004620   molecular function   phospholipase activity                                         0.01
                         GO:0042803   molecular function   protein homodimerization activity                              0.01
                         GO:0019015   cellular component   viral genome                                                   0.01
                         GO:0007156   biological process   homophilic cell adhesion                                       0.01
                         GO:0016833   molecular function   oxo-acid-lyase activity                                        0.02
                         GO:0016337   biological process   cell-cell adhesion                                             0.02
                         GO:0003913   molecular function   DNA photolyase activity                                        0.02
                         GO:0005521   molecular function   lamin binding                                                  0.02
                         GO:0046983   molecular function   protein dimerization activity                                  0.02
                         GO:0015099   molecular function   nickel cation transmembrane transporter activity               0.03
                         GO:0015675   biological process   nickel cation transport                                        0.03
                         GO:0044699   biological process   single-organism process                                        0.03
  FM^+/-^ vs WT          GO:0016485   biological process   protein processing                                             7.3 x10^-4^
                         GO:0051604   biological process   protein maturation                                             7.3 x10^-4^
                         GO:0016491   molecular function   oxidoreductase activity                                        2.62 x10^-3^
                         GO:0005787   cellular component   signal peptidase complex                                       2.94 x10^-3^
                         GO:0006465   biological process   signal peptide processing                                      2.94 x10^-3^
                         GO:0055114   biological process   oxidation-reduction process                                    4.44 x10^-3^
                         GO:0004126   molecular function   cytidine deaminase activity                                    7.06 x10^-3^
                         GO:0006216   biological process   cytidine catabolic process                                     7.06 x10^-3^
                         GO:0009972   biological process   cytidine deamination                                           7.06 x10^-3^
                         GO:0046087   biological process   cytidine metabolic process                                     7.06 x10^-3^
                         GO:0046133   biological process   pyrimidine ribonucleoside catabolic process                    7.06 x10^-3^
                         GO:0046135   biological process   pyrimidine nucleoside catabolic process                        7.06 x10^-3^
                         GO:0072529   biological process   pyrimidine-containing compound catabolic process               7.06 x10^-3^
                         GO:0003690   molecular function   double-stranded DNA binding                                    7.11 x10^-3^
                         GO:0019080   biological process   viral genome expression                                        7.86 x10^-3^
                         GO:0006518   biological process   peptide metabolic process                                      9.37 x10^-3^
                         GO:004353    molecular function   ADP binding                                                    0.01
                         GO:0004506   molecular function   squalene monooxygenase activity                                0.01
                         GO:0005135   molecular function   interleukin-3 receptor binding                                 0.02
                         GO:0043566   molecular function   structure-specific DNA binding                                 0.02
  FM^+/-^ vs FGF5^+/-^   GO:0007217   biological process   tachykinin receptor signaling pathway                          1.27 x10^-3^
                         GO:0071973   biological process   bacterial-type flagellar cell motility                         4.24 x10^-3^
                         GO:0070838   biological process   divalent metal ion transport                                   4.79 x10^-3^
                         GO:0070588   biological process   calcium ion transmembrane transport                            5.67 x10^-3^
                         GO:0072511   biological process   divalent inorganic cation transport                            8.87 x10^-3^
                         GO:0051607   biological process   defense response to virus                                      9.86 x10^-3^
                         GO:0032501   biological process   multicellular organismal process                               0.01
                         GO:0042168   biological process   heme metabolic process                                         0.01
                         GO:0072509   molecular function   divalent inorganic cation transmembrane transporter activity   0.01
                         GO:0007601   biological process   visual perception                                              0.01
                         GO:0030553   molecular function   cGMP binding                                                   0.01
                         GO:0050953   biological process   sensory perception of light stimulus                           0.01
                         GO:0003856   molecular function   3-dehydroquinate synthase activity                             0.01
                         GO:0044707   biological process   single-multicellular organism process                          0.01
                         GO:0030416   biological process   methylamine metabolic process                                  0.01
                         GO:1901160   biological process   primary amino compound metabolic process                       0.01
                         GO:0006816   biological process   calcium ion transport                                          0.01
                         GO:0050877   biological process   neurological system process                                    0.01
                         GO:0008113   molecular function   peptide-methionine (S)-S-oxide reductase activity              0.01
                         GO:0030551   molecular function   cyclic nucleotide binding                                      0.01

Pathway analysis {#sec016}
----------------

As shown in [Fig 4](#pone.0187966.g004){ref-type="fig"}, the top 20 pathways were identified by pairwise comparisons of complete DEGs lists from every group. The results from the KEGG analysis revealed many genes related to fatty acid metabolism, the peroxisome proliferator-activated receptor (PPAR) signaling pathway, the mitogen-activated protein kinase (MAPK) signaling pathway and cell adhesion molecules. Additionally, the KEGG analysis revealed several genes involved in Notch signaling, AMP-activated protein kinase (AMPK) signaling, mTOR-signaling, oxidative phosphorylation, and Jak-STAT signaling. Many genes significantly down-regulated in the FM^+/-^ goats compared to their expression in WT and FGF5^+/-^ goats were associated with fatty acid biosynthesis (*stearoyl-CoA desaturase*, *fatty acid synthase*, *ELOVL fatty acid elongase 6* and *3-hydroxyacyl-CoA dehydratase 2*) and the biosynthesis of unsaturated fatty acids (*stearoyl-CoA desaturase*, *fatty acid synthase* and *3-hydroxyacyl-CoA dehydratase 2*). Genes involved in the PPAR signaling pathway (*stearoyl-CoA desaturase*), MAPK signaling pathway \[(*mitogen-activated protein kinase 3*, MAPK3 or ERK1), (ras-related C3 botulism toxin substrate 2, RAC2), cell division cycle 25B (CDC25B), phospholipase A2 group IVE (PLA2G4E)\], biosynthesis of unsaturated fatty acids, Notch signaling (*hes family bHLH transcription factor 1* and *HES 1*), AMPK signaling (*calcium binding protein 39-like* and *fructose-bisphosphatase 1*) and mTOR-signaling (*calcium binding protein 39-like*) were also down-regulated. On the other hand, along with an increased percentage of differentially expressed gene sets between FGF5^+/-^ goats and WT goats, the DEGs clustered in the pathways of viral myocarditis, cell adhesion molecules (CAMs), antigen processing and presentation, graft-versus-host disease, leishmaniosis, allograft rejection, staphylococcus aureus infection and type I diabetes mellitus were up-regulated. Our KEGG pathway enrichment analysis of the DEGs showed that genes involved in oxidative phosphorylation (*pyro phosphatase* and *ATPase H+ transporting V0 subunit a4*) and Jak-STAT signaling (*colony stimulating factor 3*) were up-regulated after knockout of the *MSTN* gene ([Fig 5](#pone.0187966.g005){ref-type="fig"}).

![KEGG pathway enrichment analysis.\
4A: FM^+/-^ vs WT; 4B: FGF5^+/-^ vs WT. 4C: FM^+/-^ vs FGF5^+/-^.](pone.0187966.g004){#pone.0187966.g004}

![Cluster analysis of DEGs.\
Heat map of the expression levels of DEGs related to lipid, glucose, protein and oxidative phosphorylation metabolism pathways in the muscles of the goats.](pone.0187966.g005){#pone.0187966.g005}

Verification of DEGs by qRT-PCR {#sec017}
-------------------------------

To further confirm and validate the transcriptome analysis results, the RNA samples isolated for RNA-Seq were used in the qRT-PCR analysis. The DEGs were selected based on the expression profiles and the following criteria: DEGs with a fold-change (log2) ≥ 1 or fold-change (log2) ≤ -1 and a *P*-value \< 0.05. A subset of 5 genes selected from the list of DEGs was selected for qRT-PCR analysis. These genes were associated with muscle structure \[myogenic actor 5 (*Mfy5*)\], muscle fat content \[stearoyl coenzyme A dehydrogenase (*SCD*), CCAAT-enhancer-binding protein *α* (*C/EBPα*) and sterol-regulatory element binding proteins (*SREBP*)\] and muscle growth/differentiation (*MSTN*). Overall, the qPCR results showed good correspondence with the transcriptome analysis results, indicating that the RNA-Seq data were reliable and accurate ([Fig 6](#pone.0187966.g006){ref-type="fig"}). The discrepancies with respect to the ratio should be attributed to the different algorithms and sensitivity of the two techniques \[[@pone.0187966.ref073], [@pone.0187966.ref074]\].

![Relative expression levels of MSTN, SCD, C/EBPα, SREBP and Mfy5 determined by qRT-PCR and RNA-Seq.\
A: qRT-PCR; and B: RNA-Seq.](pone.0187966.g006){#pone.0187966.g006}

Discussion {#sec018}
==========

Myostatin is a powerful negative regulator of skeletal muscle growth and development. Although myostatin inhibition in skeletal muscles is valuable for agricultural applications, the molecules downstream of myostatin in skeletal muscle have not been fully identified \[[@pone.0187966.ref075]\]. Transcriptome analysis is an important method of exploring functional genes and is both the foundation and starting point for studying gene functions and structures \[[@pone.0187966.ref076]\]. Previous studies have not explored the transcriptome profile of the *MSTN* knockout goat. To our knowledge, this is the first study to investigate the effects of *MSTN* knockout on muscle hypertrophy and functionality as well as whole-body lipid metabolism in a goat model.

*FGF5* resides on chromosome 4q21.21, directly within the region of homozygosis \[[@pone.0187966.ref077]\]. FGF5, which is a member of the FGF family and has 23 related genes, regulates hair length in humans and a variety of other animals. The *FGF5* family is involved in the control of numerous physiological processes, including embryonic development, neuronal survival, wound repair and angiogenesis, but is also involved in a number of pathological responses \[[@pone.0187966.ref078]--[@pone.0187966.ref080]\]. In postnatal muscles, satellite cells are the myogenic precursors and are situated beneath the myofiber basement membrane. FGF family proteins can maintain the proliferative state of satellite cells in rat myofiber cultures; specifically, *FGF1*, *FGF4*, and *FGF6* enhance satellite cell proliferation, whereas FGF5 and FGF7 are ineffective \[[@pone.0187966.ref081]\]. Mice that are homozygous null for *FGF5* display no obvious defects in limb or axial muscle development but are characterized by substantial hair overgrowth. This finding, which is an important demonstration that *FGF5* is not required for normal limb development \[[@pone.0187966.ref082]\], provides evidence that *FGF5* is not involved in muscle development. Recent studies have suggested that the *FGF5* gene is associated with hair length and in controls the cessation of the anagen stage. *FGF5* signaling pathway is binding of canonical FGFs to FGFR with heparin sulfate as a cofactor induces the formation of ternary FGF---FGFR-HS complex, which activates the FGFR intracellular tyrosine kinase domain by phosphorylation of specific tyrosine residues. The activated receptor is coupled to intracellular RAS-MAPK signaling pathway \[[@pone.0187966.ref083], [@pone.0187966.ref084]\]. However, *MSTN* is a negative regulator of skeletal muscle development and growth, and it is expressed mainly in muscle. The myostatin-Smad pathway alters the activity of protein kinase AKT, thereby inhibiting mTOR pathway and protein synthesis \[[@pone.0187966.ref085]\]. Therefore, hitherto, no works have yet addressed the possible interaction between *MSTN* and *FGF5*. Taken together, our results support that *FGF5* has not affect the function of *MSTN*. We assessed the function and molecular mechanism of introducing myostatin dysfunction in *FGF5* knockout goats in order to compare the differences between *FGF5/MSTN* dual knockout and *FGF5* single knockout goats.

Myostatin dysfunction results in a dramatic increase of animal muscle mass due to increases in both the numbers and cross-sectional areas of myofibrils \[[@pone.0187966.ref007], [@pone.0187966.ref086]\]. In the present study, we were the first to use transcriptome analysis to identify genes expression changes caused by the knockout of *MSTN* in goats. In total, 68.93 Gb of clean data were obtained. Several DEGs involved in muscle development, fatty acid metabolism, glucose metabolism and oxidative phosphorylation were identified following *MSTN* and *FGF5* gene knockout; these results may benefit studies of the function and molecular mechanism of myostatin in goats. Changes in the downstream molecules of *MSTN*, including the increased expression levels of *MYH15* (myosin heavy chain 15), *MAPKAPK3* (mitogen-activated protein kinase-active protein kinase) and *MYOZ3* (myozenin 3) \[[@pone.0187966.ref087]--[@pone.0187966.ref089]\], indicated that functional *MSTN* activity or expression was enhanced in FM +/- goats compared to that in the FGF5 +/- and WT goats. Myostatin expression is restricted to developing skeletal muscles, but myostatin protein is still expressed and secreted by skeletal muscles in adulthood \[[@pone.0187966.ref090], [@pone.0187966.ref091]\]. Though the effects of *MSTN* knockout varies by age, no differences were found in body size and weight at birth among homozygous KO lambs and their WT counterparts. However, KO lambs were 20--30% heavier than WT lambs 60 days later despite having a similar body size \[[@pone.0187966.ref092], [@pone.0187966.ref093]\]. The causes of these results are not entirely understood, but it is clear that these results are dependent on the genetic background.

This study showed that genes related to the immune system were up-regulated in the FGF5^+/-^ group compared with the WT and FM^+/-^ groups. Overexpression of *KRT27* has been reported in the inner root sheath \[[@pone.0187966.ref052]\], and *KRT27* has been shown to regulate innate immune functions \[[@pone.0187966.ref094]\]. Furthermore, cell adhesion pathway enrichment analysis of the DEGs revealed changes in the intercellular adhesion molecule 3 (*ICAM-3*), human leukocyte antigen (HLA) class II histocompatibility antigen, BOLA class I histocompatibility antigen and HLA class II histocompatibility antigen genes. *ICAM-3*, a member of the *ICAM* immunoglobulin family of adhesion molecules, binds to leukocyte function antigen and mediates the initial localization of neutrophils to sites of tissue injury and inflammation in autoimmune diseases \[[@pone.0187966.ref095]\]. CAMs of the immunoglobulin superfamily nucleate and maintain groups of cells at key sites during early development and in the adult stage. In addition to their adhesive properties, the binding of CAMs can affect intracellular signaling and developmental events, including cell migration, proliferation, and differentiation \[[@pone.0187966.ref096]\].

Our KEGG pathway enrichment analysis of the DEGs showed that the skeletal muscle growth, fatty acid metabolism, glucose metabolism and oxidative phosphorylation pathways were enriched in DEGs after *MSTN* knockout. The DEG *HES1*, which is involved in Notch signaling, may act as a regulator of myogenesis by inhibiting the function of *MyoD1* and *ASH1*. It is well known that AMPK acts as a key energy sensor that balances anabolism and catabolism by monitoring either cellular ATP levels or glycogen content.

The MAPK signaling pathway was significantly enriched in DEGs (MAPKAPK3, RAC2, CDC25B and PLA2G4E) after knockout of the *MSTN* and *FGF5* genes. Myostatin activates Erk1/2 MAPK in both proliferating and differentiating C2C12 cells \[[@pone.0187966.ref097]\]; thus, *MSTN* may affect muscle structures in goats. The MAPK/ERK pathway is reported to be associated with cell proliferation, differentiation, migration, senescence and apoptosis \[[@pone.0187966.ref098], [@pone.0187966.ref099]\]. A wealth of data has revealed a cross-talk between myostatin and the intracellular AKT/mTOR signaling pathway, strongly supporting the notion that myostatin affects the muscle protein balance by regulating protein synthesis and degradation \[[@pone.0187966.ref100]\]. Adult muscle growth is primarily due to the increase of protein content through activation of the AKT/mTOR pathway, which regulates protein synthesis \[[@pone.0187966.ref101]\]. Inhibition of myostatin, a negative growth modulator in muscles, functionally enhances muscle mass and improves glucose and fat metabolism in myostatin propeptide transgenic mice \[[@pone.0187966.ref102]\]. Published studies have clearly shown that adipogenesis is decreased in *MSTN* KO mice. Moreover, the absence of *MSTN* results in enhanced peripheral tissue fatty acid oxidation and increased thermogenesis, culminating in increased fat utilization and reduced adipose tissue mass \[[@pone.0187966.ref103]\]. Consistent with previous studies, our study showed that fatty acid synthesis is decreased in heterozygous *MSTN* goats, and our KEGG pathway enrichment analysis of the DEGs showed that the fatty acid metabolism pathway was significantly enriched in DEGs after *MSTN* knockout in goats.

Both adipocytes and myocytes are derived from the same mesodermal precursor cells during development. C3H10T(1/2) cells, a mesenchymal fibroblast-like cell line of embryonic origin, have the capacity to undergo differentiation into multiple cell lineages, such as myoblasts, chondrocytes, and adipocytes, after incubation in different media in vitro \[[@pone.0187966.ref104]--[@pone.0187966.ref106]\]. Later, differentiation controlled by different transcriptional pathways yields individual tissues, suggesting that the myostatin gene is involved in regulating both adiposity and muscularity \[[@pone.0187966.ref092]\]. In a previous study, we used CRISPR/Cas9 technology and single cell embryo injection and showed that these two methods differ in terms of gene editing efficiency. Specifically, single cell embryo injection could result in abnormal fetus development and high fetal mortality, whereas CRISPR/Cas9 technology did not affect the health of the animals \[[@pone.0187966.ref107]\]. More importantly, the present study identified the response of some important genes, including *TNMD*, *SCD* and *FANS*, to *MSTN* disruption. These results will be beneficial for breeding purposes.

Conclusions {#sec019}
===========

In this study, we assembled, characterized, and evaluated the muscle tissue transcriptome and quantified the gene expression levels in *MSTN* and *FGF5* gene-modified goats. Through the development of a rigorous multistep bioinformatics approach, the sequencing reads obtained from *MSTN* knockout goats were successfully cleaned of host sequences and were found to contain high numbers of important genes. The results presented here and the associated assembly will help improve our understanding of the *MSTN* gene expression profile and molecular mechanisms. These data are valuable resources for future studies of goat genomics and will be beneficial for breeding applications that target multiple genes with strong effects on economically important traits in animals. Finally, the results of this study suggest that myostatin disruption might be a promising strategy for the treatment of type 2 diabetes and related metabolic diseases.

Supporting information {#sec020}
======================

###### NC3Rs ARRIVE guidelines checklist.

(DOCX)

###### 

Click here for additional data file.

###### Genotypes of six live *MSTN*- and *FGF5*-knockout goats.

(DOCX)

###### 

Click here for additional data file.

###### Primers for quantitative PCR analysis.

(DOCX)

###### 

Click here for additional data file.

This study was carried out using the animals from the Shaanbei Cashmere Goat Farm at Yulin University. The authors would like to thank all participants who were involved in our study.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.
